What are the pharmacoeconomic and

What are the pharmacoeconomic and "pain management policy" implications of your study evaluating costs and clinical metrics in bariatric surgery patients managed with IV acetaminophen?

What are the pharmacoeconomic and “pain management policy” implications of your study evaluating differential costs and clinical metrics in bariatric surgery patients managed with IV acetaminophen? What are the institutional and patient (pain-related) satisfaction implications of your study?


Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

Maher El Chaar, MD

Maher El Chaar, MD

Co-Medical Director of Bariatric Surgery
St Luke’s University Hospital
Allentown, Pennsylvania